文献速递中毒与环境急症消化、代谢与肾脏急症

大剂量安非他酮缓释片过量后粪便排出大量「幽灵药片」外壳

"Ghost tablet" husks excreted in feces in large bupropion XL overdose.
PubMed 文献 · Clin Toxicol (Phila) · 2018-08-17
一句话结论大剂量安非他酮缓释片过量后粪便中可排出大量完整「幽灵药片」外壳,应作为过量服药的物理证据记录。

本文报告一例19岁男性故意过量服用不明物质后出现癫痫持续状态,心电图示QRS与QT间期延长,低血压需血管加压药、心动过速,并进展至心脏骤停和呼吸衰竭。入院时血清安非他酮及羟基安非他酮浓度分别为1800 ng/mL和4200 ng/mL。住院第4天排出大量含疑似药片的粪便,即缓释剂型不溶性基质残留的「幽灵药片」。作者认为医护人员应认识该现象,并将其作为过量服药的物理证据加以记录。

要点

  • 大剂量安非他酮缓释片过量后,粪便中可排出大量完整「幽灵药片」外壳,为不溶性基质残留,应作为过量服药的物理证据记录。
  • 本例19岁男性过量后出现癫痫持续状态、QRS与QT间期延长、低血压需血管加压药、心动过速,并进展至心脏骤停和呼吸衰竭。
  • 入院时血清安非他酮1800 ng/mL、羟基安非他酮4200 ng/mL。
  • 「幽灵药片」此前已在治疗剂量给药过程中被报告出现于患者粪便,本例为大量安非他酮XL过量后粪便回收大量幽灵药片。
  • 作者认为医护人员应认识 poisoned patients 中该现象的可能,并将其与临床证据一同记录。

适用人群与场景

  • 故意过量服用安非他酮缓释片(XL)的患者,急诊及住院场景。

红旗征与不能漏的情况

  • 癫痫持续状态、QRS与QT间期延长、低血压需血管加压药、心动过速,并进展至心脏骤停和呼吸衰竭。

研究设计与关键结果

  • 病例报告:19岁男性故意过量服用不明物质后以癫痫持续状态就诊,心电图示QRS与QT间期延长,低血压需血管加压药,心动过速,进展至心脏骤停和呼吸衰竭;住院第4天排出大量含疑似药片的粪便;入院时血清安非他酮1800 ng/mL、羟基安非他酮4200 ng/mL。

证据类型、等级与局限

  • 证据类型:病例报告。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为医护人员应认识中毒患者中「幽灵药片」现象的可能,并将其作为过量服药的物理证据与临床证据一同记录。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Extended-release medications are widely prescribed across the spectrum of medical specialties; however, there is heterogeneity in how they are formulated. Commonly, they consist of an insoluble matrix or shell from which drug elutes, which may then be observed by patients when excreted in feces. We describe the case of a patient who ingested a large amount of extended-release bupropion tablets and subsequently passed a large number of these so-called "ghost tablets" in his stool.

CASE DETAILS: A 19-year-old male presented in status epilepticus following intentional overdose of an unknown substance. He had prolonged QRS and QT intervals on ECG, hypotension requiring vasopressors, and tachycardia, and progressed to cardiac arrest and respiratory failure. On hospital day 4, he passed several large bowel movements containing apparent tablets. Serum bupropion and hydroxybupropion levels performed on serum taken at time of admission were 1800 ng/mL and 4200 ng/mL, respectively. Case Discussion: "Ghost tablets," the insoluble remnant of some extended-release dosage forms, have been previously reported to appear in patients' stool in the course of therapeutic dosing. We present the case of a considerable quantity of these ghost tablets recovered from stool following a large bupropion XL overdose.

CONCLUSION: Healthcare providers should be aware of the potential for this phenomenon to occur in poisoned patients. It should be documented as physical evidence of overdose in addition to clinical evidence.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Overberg A, Purpura A, Nanagas K, et al. "Ghost tablet" husks excreted in feces in large bupropion XL overdose. Clin Toxicol (Phila). 2018. PMID: 30117332. doi:10.1080/15563650.2018.1494276

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。